02 August 2012 08:32

EC raises concern at Visa Europe on credit card interchange fees

Visa Europe

European regulators have formally raised concerns that consumers could be paying too much because of fees charged by Visa to process cross-border credit card transactions.

The European Commission told Visa of its concerns about "possible violations of EU antitrust rules" relating to Visa's "multilateral interchange fees" (MIFs) system, which charges retailers for the transactions they handle. 

In a supplementary statement, the Commission says that its preliminary view is that the Visa multilateral interchange fees (MIFs) for consumer credit cards violate its rules designed to stop cartels and restrictive business practices.

The EC says it thinks that MIFs "harm competition between acquiring banks, inflate the cost of payment card acceptance for merchants and ultimately increase consumer prices".

It also "doubts" that Visa's MIFs are "necessary to create efficiencies that benefit merchants and consumers" and could therefore be entitled to an exception from the rules. 

The supplementary statement is the latest stage in a lengthy battle that saw Visa slash its multilateral interchange fees for debit cards in late 2010 but refuse to back down credit cards.

Visa can now make a written reply or ask for a hearing on the issue which could see fines imposed of up to 10% of turnover imposed for antitrust breaches,

Responding to the new development, Peter Ayliffe, CEO, Visa Europe, says: "We are very disappointed that the Commission has taken such a confrontational approach and was not willing to find a solution to support investment and innovation in European payments for the benefit of European consumers and to allow European payments to compete globally." 

In May an EU court dismissed Visa rival MasterCard's challenge against an EC ruling that the firm's cross-border interchange fees for both credit and debit cards violated competition law.

Meanwhile, both card giants are facing interchange problems in the US: having agreed a $7.25 billion class action settlement with retailers earlier this month, several major merchants, including Walmart, have now come out against the plan.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
27 Jan
OMXC20
  Jeg er blevet bedt om at beskrive, hvordan man arbejder effektivt som investor. Det vil jeg gerne,..
82
26 Jan
PNDORA
At forstå Pandora er ikke bare at elske eller hade charms og evt. kalde selskabets smykker for "blik..
42
24 Jan
VWS
  På den lille ø Rügen ud for Stralsund i Tyskland var der under 2. verdenskrig en del af Hitlers vå..
25
24 Jan
VWS
Jeg kan da ikke tale en skid op. Men jeg kan dele et overblik over selskabet som andre ikke har. Men..
19
27 Jan
OMXC20
Dagblabdet Børsen bruger spalteplads til at hylde daytradere, der scorer kassen på højt gearede posi..
17
25 Jan
TORM
Torm havde væsentligt flere skibe i 2008 end de har nu, så jeg tror ikke du skal være så ked af, at ..
17
29 Jan
I:SP500
En del skribenter herinde, skriver om kursstyrt, hver gang et toneangivende index dykker, således og..
15
28 Jan
TORM
Jeg har nu i mere end 6 måneder advaret imod Torm som er 0 DKK værd..   Mange har fået en lektion so..
15
24 Jan
VWS
I stedet for at bruge så mange kræfter på mig syntes jeg at du skulle bruge dem på at lave de kritis..
15
28 Jan
BAVA
AA solgte alle aktier og betalte sin gæld. Han har lidt til overs og viser aktionærerne, at han stad..
14

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Ashland Inc. enters into approximately $270 million share repurchase agreements
2
Minerals Technologies Reports Fourth Quarter Earnings per Share of $1.22, Excluding Special Items, A 100-Percent Increase over Prior Year; Reported Earnings were $0.61 per Share
3
Results from the extraordinary general meeting of NunaMinerals A/S on 29 January 2015
4
BLACKPEARL ANNOUNCES 2014 YEAR-END RESERVES AND CONTINGENT RESOURCE ESTIMATES AND PROVIDES PRODUCTION UPDATE
5
Coloplast delivers stable growth in first quarter, but lowers its full-year sales growth guidance due to challenges in the UK an

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
30 January 2015 07:49:42
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150128.1 - EUROWEB3 - 2015-01-30 08:49:42 - 2015-01-30 07:49:42 - 1000 - Website: OKAY